#drugpatents — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #drugpatents, aggregated by home.social.
-
https://www.europesays.com/ie/450900/ Siptu seeks urgent talks with Pfizer after company confirms threat to 102 jobs – The Journal #BigPharma #Business #CoCork #cork #DrugPatents #Éire #IE #Ireland #JobCuts #JobLosses #pfizer #PfizerRingaskiddy #pharma #PharmaPatents #Ringaskiddy #SIPTU
-
The second one is that public debate, including on health policy, has been kept between a very narrow set of goalposts. Fixing Pharmac is the most ambitious thing the panelists can come up with. No discussion of abolishing drug patents - as we have with software patents - so our health system can manufacture the medicines we need at cost.
-
The second one is that public debate, including on health policy, has been kept between a very narrow set of goalposts. Fixing Pharmac is the most ambitious thing the panelists can come up with. No discussion of abolishing drug patents - as we have with software patents - so our health system can manufacture the medicines we need at cost.
-
The second one is that public debate, including on health policy, has been kept between a very narrow set of goalposts. Fixing Pharmac is the most ambitious thing the panelists can come up with. No discussion of abolishing drug patents - as we have with software patents - so our health system can manufacture the medicines we need at cost.
-
The second one is that public debate, including on health policy, has been kept between a very narrow set of goalposts. Fixing Pharmac is the most ambitious thing the panelists can come up with. No discussion of abolishing drug patents - as we have with software patents - so our health system can manufacture the medicines we need at cost.
-
"What I discovered is that... [pharmaceutical corporations] don't, by and large, invent medicines. They behave like hedge funds. They buy the rights to produce medicines that have been made by others - with public money, or at small biotech companies - and then they squeeze the most they possibly can out of those drugs Whatever the consequences are to society... [or] how unaffordable they are."
#NickDearden, 2024
https://www.currentaffairs.org/2023/11/how-big-pharma-makes-a-killing-from-letting-people-die
-
"What I discovered is that... [pharmaceutical corporations] don't, by and large, invent medicines. They behave like hedge funds. They buy the rights to produce medicines that have been made by others - with public money, or at small biotech companies - and then they squeeze the most they possibly can out of those drugs Whatever the consequences are to society... [or] how unaffordable they are."
#NickDearden, 2024
https://www.currentaffairs.org/2023/11/how-big-pharma-makes-a-killing-from-letting-people-die
-
"What I discovered is that... [pharmaceutical corporations] don't, by and large, invent medicines. They behave like hedge funds. They buy the rights to produce medicines that have been made by others - with public money, or at small biotech companies - and then they squeeze the most they possibly can out of those drugs Whatever the consequences are to society... [or] how unaffordable they are."
#NickDearden, 2024
https://www.currentaffairs.org/2023/11/how-big-pharma-makes-a-killing-from-letting-people-die
-
"What I discovered is that... [pharmaceutical corporations] don't, by and large, invent medicines. They behave like hedge funds. They buy the rights to produce medicines that have been made by others - with public money, or at small biotech companies - and then they squeeze the most they possibly can out of those drugs Whatever the consequences are to society... [or] how unaffordable they are."
#NickDearden, 2024
https://www.currentaffairs.org/2023/11/how-big-pharma-makes-a-killing-from-letting-people-die
-
Biden administration asserts power to seize drug patents in move to slash high prices
https://www.cnbc.com/2023/12/07/biden-administration-asserts-power-to-seize-drug-patents.html
#BidenAdministration #DrugPatents #HighPrices #SeizePatents #SlashPrices #Pharmaceuticals #Politics #News
-
After Decades of Pressure, US Drugmaker J&J Gives Up Patent on Life-Saving TB Drug
This move can lead to the entry of many manufacturers of bedaquiline, thereby reducing the exorbitant price which many governments currently find difficult to afford for all of their patients, say activists.
#tuberculosis #JohnsonAndJohnson #bedaquiline #sirturo #DrugResistantTB #DRTB #LMICs #DrugPatents #drugs #medicine #health #healthcare #india